Long‐term continuous subcutaneous insulin infusion (CSII) and cardiovascular complications: Higher fractional use is not biased by risk factors
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3306
Abstract: Dear Editor, In our previous report performed on 141 people with type 1 diabetes (T1D) with long-term (more than 10 years) use of insulin pump, we have demonstrated that longer period on CSII treatment, in… read more here.
Keywords: use; fractional use; long term; risk factors ... See more keywords
Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Pediatric Psychology"
DOI: 10.1093/jpepsy/jsy064
Abstract: Objectives Type 1 diabetes (T1D) poses unique challenges to adherence-related behavior because of complex treatment regimens that vary by use of specific technologies. This study used objective data to determine (1) prevalence rates of adherence… read more here.
Keywords: insulin pump; multiple daily; type diabetes; csii ... See more keywords
Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control
Sign Up to like & getrecommendations! Published in 2017 at "Diabetic Medicine"
DOI: 10.1111/dme.13367
Abstract: In the short term, continuous subcutaneous insulin infusion (CSII) has been associated with improved glycaemic control, reduced hypoglycaemia and improved quality of life (QOL). However, limited data are available on its long‐term benefits, particularly in… read more here.
Keywords: subcutaneous insulin; infusion csii; insulin infusion; csii ... See more keywords
G229(P) Longitudinal audit of diabetes control with insulin pump therapy over seven years of treatment – interim results
Sign Up to like & getrecommendations! Published in 2018 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2018-rcpch.224
Abstract: Aim Insulin pump therapy i.e. Continuous Subcutaneous Insulin Infusion therapy (CSII) is a well-recognised treatment modality in Type 1 Diabetes Mellitus (T1DM). NICE recommends a target%HbA1c level ≤6.5% to minimise long-term complication risk1. CSII can be… read more here.
Keywords: patients managed; hba1c; diabetes control; csii ... See more keywords
Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Health Psychology"
DOI: 10.1177/13591053221098498
Abstract: This cross-sectional observational study assesses differences in depressive symptoms and diabetes-distress between adults with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) insulin delivery methods. Two-hundred and seventy-one adults… read more here.
Keywords: diabetes distress; continuous subcutaneous; symptoms diabetes; subcutaneous insulin ... See more keywords
New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "Systematic Reviews"
DOI: 10.1186/s13643-019-1171-9
Abstract: BackgroundOptimal type 1 diabetes mellitus (T1D) care requires lifelong appropriate insulin treatment, which can be provided either by multiple daily injections (MDI) of insulin or by continuous subcutaneous insulin infusion (CSII). An increasing number of… read more here.
Keywords: insulin; young patients; csii; review ... See more keywords
CSII Use in Hospitalized Patients—Adherence to Policy and Safety of Use
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-975-p
Abstract: Continuous subcutaneous insulin infusion (CSII) therapy is routinely used in diabetes management for patients expecting to use their insulin pumps during hospitalizations. For hospital personnel, this is unfamiliar and complex technology, which necessitates implementing policies… read more here.
Keywords: policy; use; csii; csii use ... See more keywords
Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes Care"
DOI: 10.2337/dc19-0888
Abstract: OBJECTIVE This study assessed the clinical impact of four treatment strategies in adults with type 1 diabetes (T1D): real-time continuous glucose monitoring (rtCGM) with multiple daily insulin injections (rtCGM+MDI), rtCGM with continuous subcutaneous insulin infusion… read more here.
Keywords: csii; rtcgm mdi; smbg csii; smbg ... See more keywords
Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Sign Up to like & getrecommendations! Published in 2018 at "Health technology assessment"
DOI: 10.3310/hta22420
Abstract: BACKGROUND The risk of developing long-term complications of type 1 diabetes (T1D) is related to glycaemic control and is reduced by the use of intensive insulin treatment regimens: multiple daily injections (MDI) (≥ 4) and continuous… read more here.
Keywords: insulin; mdi; treatment; csii ... See more keywords
Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.604028
Abstract: Objectives To evaluate the clinical and economic consequences of continuous subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) in children and adolescents with type 1 diabetes mellitus (T1DM) from a public health care system… read more here.
Keywords: health care; csii; care system;